Brendan J. Guercio

1.3k total citations · 1 hit paper
22 papers, 488 citations indexed

About

Brendan J. Guercio is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Brendan J. Guercio has authored 22 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Brendan J. Guercio's work include Bladder and Urothelial Cancer Treatments (9 papers), Cancer, Lipids, and Metabolism (3 papers) and Dementia and Cognitive Impairment Research (3 papers). Brendan J. Guercio is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Cancer, Lipids, and Metabolism (3 papers) and Dementia and Cognitive Impairment Research (3 papers). Brendan J. Guercio collaborates with scholars based in United States, Hungary and Italy. Brendan J. Guercio's co-authors include Antonio López-Beltrán, Liang Cheng, Michael S. Cookson, Keith A. Johnson, Gad A. Marshall, Dorene M. Rentz, Nancy J. Donovan, Rebecca E. Amariglio, Reisa A. Sperling and William J. Bowers and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Brendan J. Guercio

19 papers receiving 483 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in diagnosis and treatment of bladder cancer

2024 183 citations Antonio López-Beltrán, Michael S. Cookson et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brendan J. Guercio United States	9	143	123	103	101	91	22	488
Alícia Costa Spain	13	149 1.0×	95 0.8×	85 0.8×	225 2.2×	60 0.7×	21	686
Rahşan Kemerdere Türkiye	14	117 0.8×	49 0.4×	21 0.2×	107 1.1×	75 0.8×	57	572
Jun Matsushima Japan	15	48 0.3×	26 0.2×	59 0.6×	148 1.5×	33 0.4×	41	493
Seung Chan Kim South Korea	10	45 0.3×	62 0.5×	102 1.0×	113 1.1×	12 0.1×	37	436
Xiang Cai China	12	84 0.6×	69 0.6×	32 0.3×	139 1.4×	28 0.3×	22	546
E. Bernd Ringelstein Germany	10	38 0.3×	40 0.3×	81 0.8×	40 0.4×	77 0.8×	12	319
Weibo Liu China	12	52 0.4×	113 0.9×	14 0.1×	106 1.0×	82 0.9×	37	419
Yanchang Shang China	11	83 0.6×	33 0.3×	78 0.8×	233 2.3×	40 0.4×	27	524
W. Poewe Austria	9	51 0.4×	54 0.4×	29 0.3×	46 0.5×	71 0.8×	22	513

Countries citing papers authored by Brendan J. Guercio

Since Specialization

Citations

This map shows the geographic impact of Brendan J. Guercio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan J. Guercio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan J. Guercio more than expected).

Fields of papers citing papers by Brendan J. Guercio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendan J. Guercio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan J. Guercio. The network helps show where Brendan J. Guercio may publish in the future.

Co-authorship network of co-authors of Brendan J. Guercio

This figure shows the co-authorship network connecting the top 25 collaborators of Brendan J. Guercio. A scholar is included among the top collaborators of Brendan J. Guercio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan J. Guercio. Brendan J. Guercio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guercio, Brendan J., Karissa Whiting, Ronak Shah, et al.. (2025). Circulating Tumor DNA and Response to Cisplatin-based Chemotherapy in Patients with Metastatic Urothelial Carcinoma Enrolled in CALGB 90601 (Alliance). European Urology Open Science. 75. 80–88.

Mooser, Catherine, Nicolas Jonsson, Matteo Cagiada, et al.. (2025). Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancer. Journal of Clinical Investigation. 135(16).

Guercio, Brendan J., et al.. (2025). The Microbiome and Genitourinary Cancers: A New Frontier. Cancers. 17(22). 3606–3606. 1 indexed citations

Guercio, Brendan J., Min Yuen Teo, Ashley Marie Regazzi, et al.. (2024). Associations of dietary fructose with survival of patients (pts) with metastatic cancer of the urothelium (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB).. Journal of Clinical Oncology. 42(16_suppl). 4571–4571. 1 indexed citations

MacLaughlan, Shannon, Daniela Matei, Min Ji Song, et al.. (2024). 744P A phase II study of ACR-368 in patients with ovarian (OvCa) or endometrial carcinoma (EnCa) and prospective validation of OncoSignature patient selection (NCT05548296). Annals of Oncology. 35. S564–S565. 1 indexed citations

López-Beltrán, Antonio, Michael S. Cookson, Brendan J. Guercio, & Liang Cheng. (2024). Advances in diagnosis and treatment of bladder cancer. BMJ. 384. e076743–e076743. 183 indexed citations breakdown →

Guercio, Brendan J., et al.. (2023). Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer. Cancers. 15(15). 3969–3969. 17 indexed citations

Guercio, Brendan J., Min Yuen Teo, Ashley Marie Regazzi, et al.. (2023). Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB).. Journal of Clinical Oncology. 41(16_suppl). 4598–4598. 1 indexed citations

Teo, Min Yuen, Brendan J. Guercio, Eugene J. Pietzak, et al.. (2023). Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC).. Journal of Clinical Oncology. 41(6_suppl). 511–511. 1 indexed citations

10.

Guercio, Brendan J., Eugene J. Pietzak, Samantha Brown, et al.. (2022). Neoadjuvant nivolumab (N) +/- ipilimumab (I) in cisplatin-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC).. Journal of Clinical Oncology. 40(6_suppl). 498–498. 9 indexed citations

11.

Guercio, Brendan J., Michal Sarfaty, Min Yuen Teo, et al.. (2022). Abstract 3410: Identifying potential mechanisms of resistance to erdafitinib (erda) via longitudinal analysis of circulating tumor (ct)-DNA of patients (pts) with advanced/metastatic urothelial cancer (mUC). Cancer Research. 82(12_Supplement). 3410–3410. 1 indexed citations

12.

Tsai, Frederick D., Brendan J. Guercio, Sherri O. Stuver, et al.. (2021). Resident-Reported Impact of a Novel Oncology Curriculum for Internal Medicine Residents. Journal of Cancer Education. 37(6). 1879–1885.

13.

Guercio, Brendan J., Gopa Iyer, & Jonathan E. Rosenberg. (2021). Developing Precision Medicine for Bladder Cancer. Hematology/Oncology Clinics of North America. 35(3). 633–653. 11 indexed citations

14.

Guercio, Brendan J., Gopa Iyer, Wajih Zaheer Kidwai, et al.. (2021). Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report. Case Reports in Oncology. 14(1). 430–438. 14 indexed citations

15.

Guercio, Brendan J., Jatin Gandhi, Min Yuen Teo, et al.. (2021). Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience.. Journal of Clinical Oncology. 39(15_suppl). 4526–4526. 2 indexed citations

16.

Guercio, Brendan J., Sui Zhang, Alan P. Venook, et al.. (2020). Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectrum. 4(3). pkaa024–pkaa024. 8 indexed citations

17.

Guercio, Brendan J., Alan P. Venook, Donna Niedzwiecki, et al.. (2017). Associations of physical activity with survival and progression in metastatic colorectal cancer: Results from CALGB 80405 (Alliance).. Journal of Clinical Oncology. 35(4_suppl). 659–659. 2 indexed citations

18.

Guercio, Brendan J., Nancy J. Donovan, Catherine E. Munro, et al.. (2015). The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment. Journal of Alzheimer s Disease. 47(2). 421–432. 72 indexed citations

19.

Guercio, Brendan J., Nancy J. Donovan, Andrew Ward, et al.. (2014). Apathy is Associated With Lower Inferior Temporal Cortical Thickness in Mild Cognitive Impairment and Normal Elderly Individuals. Journal of Neuropsychiatry. 27(1). e22–e27. 47 indexed citations

20.

Desai, Maya, Brendan J. Guercio, Wade C. Narrow, & William J. Bowers. (2011). An Alzheimer's disease‐relevant presenilin‐1 mutation augments amyloid‐beta‐induced oligodendrocyte dysfunction. Glia. 59(4). 627–640. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact